Company / Revenue per Share
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Revenue per Share History
FY2016-FY2018 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.68
FY2018
5-year range
-
FY2016-FY2018
Trend
-33.0%
vs FY2017
Sector context
#148 of 153
Health Care
What the data says
Among 153 Health Care companies, PACIFIC BIOSCIENCES OF CALIFORNIA, INC. is in the bottom 3% for revenue per share. Declined from $1.13 to $0.68 over the past 2 years.
Based on SEC 10-K filings.
0.68 in FY2018.
Declined from $1.13 to $0.68 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 153This company $0.68 Sector average $123.62
▼
-99.5% below sector average
Key checks
Key Insights
- In FY2018, revenue per share decreased 33.0% year-over-year.
- Ranks #148 out of 153 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | $0.68 | -33.0% |
| FY2017 | $1.01 | -11.1% |
| FY2016 | $1.13 | +197.5% |
As of FY2018 · SEC 10-K · Updated Jun 30, 2026